Esomeprazole magnesium brand name
Pro Research Analysisby 
Searched over 200M research papers
Esomeprazole Magnesium Brand Name: Nexium
Introduction to Esomeprazole Magnesium
Esomeprazole magnesium is a proton-pump inhibitor (PPI) used primarily for the treatment of gastroesophageal reflux disease (GERD), healing and maintenance of erosive esophagitis, and as part of a regimen for Helicobacter pylori infection. It is the S-isomer of omeprazole, which may offer improved pharmacokinetic and pharmacodynamic characteristics compared to other PPIs.
Brand Name: Nexium
The brand name for esomeprazole magnesium is Nexium. Nexium is widely recognized and used for its efficacy in maintaining intragastric pH at a higher level for a longer period, which is beneficial in treating conditions like GERD and erosive esophagitis.
Pharmacokinetics and Bioequivalence
Pharmacokinetics in Healthy Subjects
Studies have shown that esomeprazole magnesium, whether in generic or brand formulations, exhibits similar pharmacokinetic properties. For instance, a study conducted on healthy Chinese subjects under both fasting and fed conditions demonstrated that the pharmacokinetics of a generic formulation were comparable to the brand reference formulation. The geometric mean ratios (GMRs) for Cmax and AUC fell within the bioequivalence range of 80-125%, indicating that both formulations are bioequivalent and well-tolerated.
Bioequivalence Studies
Further research on the bioequivalence of esomeprazole magnesium delayed-release oral suspension compared to its marketed counterpart also confirmed that both formulations are bioequivalent under fasting and fed states. The 90% confidence intervals for the ratio of geometric means of Cmax, AUC0-t, and AUC0-∞ were within the equivalence range, and no severe adverse events were reported.
In Vitro Release Kinetics
Comparison with Originator Brand
In vitro studies conducted in Bangladesh compared the dissolution patterns of various national and international brands of esomeprazole magnesium with the originator brand, Nexium. While most brands complied with the USP in-vitro dissolution specifications, some did not meet the dissolution pattern of the originator brand. However, a few brands showed a dissolution pattern and release kinetics very close to Nexium .
Release Kinetics Analysis
The release kinetics of esomeprazole magnesium tablets were analyzed using zero order, first order, and Higuchi equations. It was found that the originator brand, Nexium, predominantly followed first-order kinetics, while other brands exhibited a mix of zero order and Higuchi release kinetics .
Clinical Efficacy and Safety
Esomeprazole magnesium, marketed as Nexium, has demonstrated clinical efficacy in the treatment of GERD, healing of erosive esophagitis, and eradication of H. pylori infection when used in combination with antibiotics. The drug is generally well-tolerated, with common adverse effects including headache, respiratory infection, and abdominal symptoms.
Conclusion
Esomeprazole magnesium, under the brand name Nexium, is a highly effective PPI with proven bioequivalence to generic formulations. It maintains a higher intragastric pH for longer periods, making it a preferred choice for treating GERD and related conditions. Both clinical and in vitro studies support its efficacy and safety, solidifying its position as a reliable treatment option.
Sources and full results
Most relevant research papers on this topic